ストックスクリーナーアプリを入手
31.82
1.73%
0.54
前日終値:
$31.28
開ける：
$31.73
24時間の取引高:
1.33M
Relative Volume:
0.71
時価総額：
$3.07B
収益：
$522.75M
当期純損益:
$-558.99M
株価収益率:
-4.9181
EPS:
-6.47
ネットキャッシュフロー:
$-439.53M
1週間 パフォーマンス:
+6.21%
1か月 パフォーマンス:
+10.03%
6か月 パフォーマンス:
-22.14%
1年 パフォーマンス:
-43.63%
1日の値動き範囲:
$31.28
$32.26
1週間の範囲:
$30.43
$32.58
52週間の値動き範囲:
$25.81
$60.37
Ultragenyx Pharmaceutical Inc Stock (RARE) Company Profile
名前
Ultragenyx Pharmaceutical Inc
セクター
電話
415-483-8800
住所
60 LEVERONI COURT, NOVATO, CA
RARE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RARE
Ultragenyx Pharmaceutical Inc
|
31.82 | 3.01B | 522.75M | -558.99M | -439.53M | -6.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Ultragenyx Pharmaceutical Inc Stock (RARE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-28 | 再開されました | H.C. Wainwright | Buy |
| 2025-05-28 | 開始されました | William Blair | Outperform |
| 2024-06-06 | アップグレード | Goldman | Neutral → Buy |
| 2024-04-22 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-12-08 | 開始されました | Wells Fargo | Overweight |
| 2023-06-14 | 再開されました | Credit Suisse | Outperform |
| 2023-06-06 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-04-26 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-01-18 | 再開されました | Canaccord Genuity | Buy |
| 2022-12-30 | 再開されました | H.C. Wainwright | Buy |
| 2022-11-03 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2022-10-13 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-08-01 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-03-16 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2022-02-11 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-09-30 | 開始されました | H.C. Wainwright | Buy |
| 2021-08-19 | 開始されました | UBS | Sell |
| 2021-07-15 | 開始されました | Guggenheim | Neutral |
| 2021-06-29 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-06-04 | 再開されました | Robert W. Baird | Neutral |
| 2021-05-06 | アップグレード | Citigroup | Neutral → Buy |
| 2021-05-06 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Neutral |
| 2021-03-02 | 再開されました | Stifel | Buy |
| 2021-02-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-12-07 | ダウングレード | Wedbush | Outperform → Neutral |
| 2020-11-24 | 再開されました | Evercore ISI | In-line |
| 2020-11-12 | ダウングレード | BofA Securities | Buy → Neutral |
| 2019-08-02 | 再開されました | Wedbush | Outperform |
| 2019-03-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-02-22 | 再開されました | Raymond James | Outperform |
| 2019-01-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2018-11-08 | アップグレード | Citigroup | Sell → Neutral |
| 2018-09-10 | 開始されました | Morgan Stanley | Equal-Weight |
| 2018-06-21 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2018-05-11 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-05-10 | 開始されました | Goldman | Neutral |
| 2018-04-18 | アップグレード | SunTrust | Hold → Buy |
| 2018-03-22 | 再開されました | Piper Jaffray | Overweight |
| 2018-02-21 | 繰り返されました | Stifel | Buy |
| 2018-01-22 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-01-18 | 開始されました | Credit Suisse | Outperform |
| 2017-12-05 | 繰り返されました | Barclays | Equal Weight |
| 2017-12-04 | アップグレード | Jefferies | Hold → Buy |
| 2017-09-14 | アップグレード | Wedbush | Neutral → Outperform |
すべてを表示
Ultragenyx Pharmaceutical Inc (RARE) 最新ニュース
Real time scanner hits for Ultragenyx Pharmaceutical Inc. explained2025 Top Gainers & Consistent Profit Alerts - Newser
Ultragenyx Pharmaceutical Inc. stock daily chart insightsShort Setup & Daily Risk Controlled Trade Plans - Newser
Institutional scanner results for Ultragenyx Pharmaceutical Inc.Market Sentiment Report & Entry Point Confirmation Alerts - Newser
How to use Fibonacci retracement on Ultragenyx Pharmaceutical Inc.Weekly Trend Report & Fast Gain Stock Tips - Newser
Live market analysis of Ultragenyx Pharmaceutical Inc.Portfolio Risk Report & Fast Exit Strategy with Risk Control - Newser
What machine learning models say about Ultragenyx Pharmaceutical Inc.July 2025 Market Mood & Verified Technical Trade Signals - Newser
What earnings revisions data tells us about Ultragenyx Pharmaceutical Inc.2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Is Ultragenyx Pharmaceutical Inc. stock a good pick for beginnersGap Up & Long-Term Growth Plans - خودرو بانک
Ultragenyx Pharmaceutical Inc. recovery potential after sell offWeekly Investment Report & Safe Entry Point Identification - Newser
Applying sector rotation models to Ultragenyx Pharmaceutical Inc.July 2025 Selloffs & Safe Capital Growth Tips - Newser
Real time pattern detection on Ultragenyx Pharmaceutical Inc. stock2025 Investor Takeaways & Risk Managed Trade Strategies - Newser
Rare Disease Therapy Approvals By FDA Speed Up Via New ProcessNeurogene (NASDAQ:NGNE) - Benzinga
Ultragenyx’s Strategic Momentum: A Rare Disease Biotech on the Cusp of Multiple Catalysts - AInvest
Ultragenyx's Strategic Momentum in Rare Disease Innovation and Commercialization - AInvest
Transcript : Ultragenyx Pharmaceutical Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 10 - MarketScreener
Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y - MSN
News impact scoring models applied to Ultragenyx Pharmaceutical Inc.Weekly Risk Report & Entry Point Confirmation Signals - Newser
Long term hold vs stop loss in Ultragenyx Pharmaceutical Inc.Global Markets & Low Risk High Reward Trade Ideas - Newser
What does recent volatility data suggest for Ultragenyx Pharmaceutical Inc.2025 Key Lessons & High Accuracy Investment Signals - Newser
A | Is Ultragenyx Pharmaceutical Inc. stock good for income investorsJuly 2025 Review & Stepwise Trade Signal Guides - خودرو بانک
Reversal indicators forming on Ultragenyx Pharmaceutical Inc. stockGap Up & Weekly Return Optimization Plans - Newser
How to build a dashboard for Ultragenyx Pharmaceutical Inc. stockTrade Volume Report & Risk Controlled Daily Trade Plans - Newser
Order flow analysis tools used on Ultragenyx Pharmaceutical Inc.July 2025 Gainers & Consistent Growth Equity Picks - Newser
Intraday pattern recognizer results for Ultragenyx Pharmaceutical Inc.Quarterly Profit Review & Community Consensus Trade Signals - Newser
Ultragenyx Pharmaceutical shares rise 1.43% after-hours following a class action investigation announcement. - AInvest
What indicators show strength in Ultragenyx Pharmaceutical Inc.2025 Institutional Moves & Detailed Earnings Play Strategies - Newser
Does Ultragenyx Pharmaceutical Inc. offer margin of safetyTreasury Yields & Real-Time Volume Analysis Alerts - خودرو بانک
Trend analysis for Ultragenyx Pharmaceutical Inc. this weekQuarterly Profit Summary & Low Drawdown Trading Techniques - Newser
How to interpret RSI for Ultragenyx Pharmaceutical Inc. stockMarket Performance Report & Long-Term Capital Growth Strategies - Newser
How hedge fund analytics apply to Ultragenyx Pharmaceutical Inc. stockShort Setup & Weekly Chart Analysis and Guides - Newser
Will earnings trigger a reversal in Ultragenyx Pharmaceutical Inc.Portfolio Value Summary & Weekly Watchlist of Top Performers - Newser
Top chart patterns to watch in Ultragenyx Pharmaceutical Inc.2025 Support & Resistance & Verified Chart Pattern Trade Signals - Newser
Quantitative breakdown of Ultragenyx Pharmaceutical Inc. recent moveCEO Change & Entry Point Confirmation Signals - Newser
Ultragenyx Pharmaceutical Inc. stock trend forecastInsider Buying & Weekly Watchlist for Consistent Profits - Newser
Is Ultragenyx Pharmaceutical Inc. stock good for income investorsJuly 2025 Rallies & Weekly Market Pulse Alerts - خودرو بانک
Can Ultragenyx Pharmaceutical Inc. ride the EV waveTrade Exit Summary & AI Optimized Trading Strategy Guides - خودرو بانک
What’s the outlook for Ultragenyx Pharmaceutical Inc.’s sectorPortfolio Growth Summary & Weekly Market Pulse Updates - خودرو بانک
Published on: 2025-09-02 13:45:06 - Newser
Pomerantz LLP Investigates Claims Against Ultragenyx Pharmaceutical Inc. - AInvest
Full technical analysis of Ultragenyx Pharmaceutical Inc. stockWeekly Stock Summary & AI Forecast Swing Trade Picks - Newser
Is Ultragenyx Pharmaceutical Inc. being accumulated by smart moneyCPI Data & Weekly High Momentum Picks - خودرو بانک
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc.RARE - Your Wyoming Link
Ultragenyx Pharmaceutical Inc (RARE) 財務データ
収益
当期純利益
現金流量
EPS
1.40%
大文字化:
|
ボリューム (24 時間):